Skip to content
★ Sign in to follow
GD

George dArbeloff V

Biolase, Inc
Total declarations
7
Company
1
▲ Purchases (4 ops.)
€62k
▼ Sales (0 ops.)
—

Latest filing published 28 May 2008 for BIOLASE, INC, €5,934.

Insider track record

Disclosed buys
4
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
4

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

George dArbeloff V: trading record in brief

George dArbeloff V appears in our data through filings on Biolase, Inc shares, published by SEC (Form 4). In total, 7 filings cover trades dated from 13 October 2006 to 27 May 2008.

The open-market record is one-sided, with 4 purchases worth €62k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant and 2 option exercises. 2008 to date brings 4 purchases and no sales.

A typical purchase (the median) is worth €13k.

Most recently, on 28 May 2008, the filings show an open-market purchase worth €5,934 in Biolase, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to George dArbeloff V

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ▲
    DirectorExecutivesBiolase, Inc
    9,367 USD0SEC
    2,900 shares@ US$3.23Common StockSEC:0001209191-08-033513:0
    Canonical exit: 21 Aug 2008 (T+90)
  • ▲
    DirectorExecutivesBiolase, Inc
    9,007 USD0SEC
    2,780 shares@ US$3.24Common StockSEC:0001209191-08-033513:1
    Canonical exit: 21 Aug 2008 (T+90)
  • ▲
    DirectorExecutivesBiolase, Inc
    46,540 USD0SEC
    14,320 shares@ US$3.25Common StockSEC:0001209191-08-033513:2
    Canonical exit: 21 Aug 2008 (T+90)
  • ▲
    DirectorExecutivesBiolase, Inc
    32,400 USD0SEC
    10,000 shares@ US$3.24Common StockSEC:0001209191-08-033513:3
    Canonical exit: 25 Aug 2008 (T+90)
  • ◇
    DirectorExecutivesBiolase, Inc
    78,800 USD0SEC
    20,000 shares@ US$3.94Common StockSEC:0001209191-07-031622:0
  • ◆
    DirectorExecutivesBiolase, Inc
    59,400 USD0SEC
    10,000 shares@ US$5.94Common StockSEC:0001209191-07-031622:1
  • ◇
    DirectorExecutivesBiolase, Inc
    29,673 USD0SEC
    8,335 shares@ US$3.56Common StockSEC:0001358010-06-000021:0

7 of 7 declarations